Skip to content

Clinical trials

Completed Amyloidosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Status: Completed Country / region: United Kingdom Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20101
20112
20134
20141
20151
20162
20172
20192
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ionis Pharmaceuticals, Inc.4
Alnylam Pharmaceuticals3
GlaxoSmithKline3
Pfizer3
Eidos Therapeutics, a BridgeBio company2
Bellus Health Inc. - a GSK company1
Boston University1
C.T. Development America, Inc.1
Intellia Therapeutics1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis22
Amyloid Neuropathies, Familial10
Alzheimer Disease5
Cardiomyopathies5
Immunoglobulin Light-chain Amyloidosis4
Amyloidosis, Familial2
Polyneuropathies2
Amyloid Neuropathies1
Arthritis, Rheumatoid1
Familial Mediterranean Fever1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.